Your browser doesn't support javascript.
loading
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.
Place, Andrew E; Goldsmith, Kelly; Bourquin, Jean-Pierre; Loh, Mignon L; Gore, Lia; Morgenstern, Daniel A; Sanzgiri, Yeshwant; Hoffman, David; Zhou, Ying; Ross, Jeremy A; Prine, Betty; Shebley, Mohamad; McNamee, Megan; Farazi, Thalia; Kim, Su Young; Verdugo, Maria; Lash-Fleming, Leanne; Zwaan, C Michel; Vormoor, Josef.
Afiliação
  • Place AE; Dana-Farber/Boston Children's Cancer & Blood Disorders Center, Boston, MA, USA.
  • Goldsmith K; School of Medicine, Emory University, Atlanta, GA, USA.
  • Bourquin JP; Cancer Research Center, University Children's Hospital & Children's Research Center, Zurich, Switzerland.
  • Loh ML; Department of Pediatrics, Benioff Children's Hospital & the Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
  • Gore L; School of Medicine & Children's Hospital Colorado, University of Colorado, Aurora, CO, USA.
  • Morgenstern DA; Department of Paediatrics, Hospital for Sick Children & University of Toronto, Toronto, ON, Canada.
  • Sanzgiri Y; AbbVie Inc., North Chicago, IL, USA.
  • Hoffman D; AbbVie Inc., North Chicago, IL, USA.
  • Zhou Y; AbbVie Inc., North Chicago, IL, USA.
  • Ross JA; AbbVie Inc., North Chicago, IL, USA.
  • Prine B; AbbVie Inc., North Chicago, IL, USA.
  • Shebley M; AbbVie Inc., North Chicago, IL, USA.
  • McNamee M; AbbVie Inc., North Chicago, IL, USA.
  • Farazi T; Genentech Inc., South San Francisco, CA, USA.
  • Kim SY; AbbVie Inc., North Chicago, IL, USA.
  • Verdugo M; AbbVie Inc., North Chicago, IL, USA.
  • Lash-Fleming L; AbbVie Inc., North Chicago, IL, USA.
  • Zwaan CM; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, & Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Vormoor J; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University & Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Future Oncol ; 14(21): 2115-2129, 2018 Sep.
Article em En | MEDLINE | ID: mdl-29595064
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Protocolos Clínicos / Compostos Bicíclicos Heterocíclicos com Pontes / Desenvolvimento de Medicamentos / Neoplasias / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Child, preschool / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Protocolos Clínicos / Compostos Bicíclicos Heterocíclicos com Pontes / Desenvolvimento de Medicamentos / Neoplasias / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Child, preschool / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article